141 related articles for article (PubMed ID: 23697346)
1. PA21, a new iron-based noncalcium phosphate binder, prevents vascular calcification in chronic renal failure rats.
Phan O; Maillard M; Peregaux C; Mordasini D; Stehle JC; Funk F; Burnier M
J Pharmacol Exp Ther; 2013 Aug; 346(2):281-9. PubMed ID: 23697346
[TBL] [Abstract][Full Text] [Related]
2. Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
Phan O; Maillard M; Malluche HH; Stehle JC; Funk F; Burnier M
Biomed Res Int; 2015; 2015():515606. PubMed ID: 26221597
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.
Neven E; Corremans R; Vervaet BA; Funk F; Walpen S; Behets GJ; D'Haese PC; Verhulst A
Nephrol Dial Transplant; 2020 Oct; 35(10):1689-1699. PubMed ID: 33022710
[TBL] [Abstract][Full Text] [Related]
4. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.
Yaguchi A; Tatemichi S; Takeda H; Kobayashi M
PLoS One; 2017; 12(7):e0180430. PubMed ID: 28704404
[TBL] [Abstract][Full Text] [Related]
7. Ferric citrate hydrate, a new phosphate binder, prevents the complications of secondary hyperparathyroidism and vascular calcification.
Iida A; Kemmochi Y; Kakimoto K; Tanimoto M; Mimura T; Shinozaki Y; Uemura A; Matsuo A; Matsushita M; Miyamoto K
Am J Nephrol; 2013; 37(4):346-58. PubMed ID: 23548309
[TBL] [Abstract][Full Text] [Related]
8. Vascular calcification is associated with cortical bone loss in chronic renal failure rats with and without ovariectomy: the calcification paradox.
De Schutter TM; Neven E; Persy VP; Behets GJ; Postnov AA; De Clerck NM; D'Haese PC
Am J Nephrol; 2011; 34(4):356-66. PubMed ID: 21876348
[TBL] [Abstract][Full Text] [Related]
9. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
[TBL] [Abstract][Full Text] [Related]
10. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E
J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
[TBL] [Abstract][Full Text] [Related]
11. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
Katsumata K; Kusano K; Hirata M; Tsunemi K; Nagano N; Burke SK; Fukushima N
Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739
[TBL] [Abstract][Full Text] [Related]
12. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
De Schutter TM; Behets GJ; Geryl H; Peter ME; Steppan S; Gundlach K; Passlick-Deetjen J; D'Haese PC; Neven E
Kidney Int; 2013 Jun; 83(6):1109-17. PubMed ID: 23486515
[TBL] [Abstract][Full Text] [Related]
13. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
14. Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats.
De Schutter TM; Behets GJ; Jung S; Neven E; D'Haese PC; Querfeld U
Calcif Tissue Int; 2012 Nov; 91(5):307-15. PubMed ID: 22926202
[TBL] [Abstract][Full Text] [Related]
15. Quercetin Attenuates Vascular Calcification through Suppressed Oxidative Stress in Adenine-Induced Chronic Renal Failure Rats.
Chang XY; Cui L; Wang XZ; Zhang L; Zhu D; Zhou XR; Hao LR
Biomed Res Int; 2017; 2017():5716204. PubMed ID: 28691026
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
[TBL] [Abstract][Full Text] [Related]
17. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?
Behets GJ; Dams G; Vercauteren SR; Damment SJ; Bouillon R; De Broe ME; D'Haese PC
J Am Soc Nephrol; 2004 Aug; 15(8):2219-28. PubMed ID: 15284308
[TBL] [Abstract][Full Text] [Related]
18. Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats.
Neven E; Dams G; Postnov A; Chen B; De Clerck N; De Broe ME; D'Haese PC; Persy V
Nephrol Dial Transplant; 2009 Jun; 24(6):1790-9. PubMed ID: 19144999
[TBL] [Abstract][Full Text] [Related]
19. Magnesium Citrate Protects Against Vascular Calcification in an Adenine-induced Chronic Renal Failure Rat Model.
Yao Z; Xu Y; Ma W; Sun XY; Jia S; Zheng Y; Liu X; Fan Y; Wang C
J Cardiovasc Pharmacol; 2018 Dec; 72(6):270-276. PubMed ID: 29738375
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K; Tanaka M; Hashiguchi J; Funakoshi S; Nakano H; Kubo H; Kono T; Uchino J; Masaki K; Date T; Shigematsu T;
Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
